A new antidiabetic agent, BRL 49 653, reduces lipid availability and improves insulin action and glucoregulation in the rat. - Oakes,N.D.; Kennedy,C.J.; Jenkins,A.B.; Laybutt,D.R.; Chisholm,D.J.; Kraegen,E.W. (Diabetes, 1994)